Nasdaq biol.
BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's ...
Nasdaq +78.81(+0.55%) Russell 2000 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) BIOLASE, Inc. (BIOL) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W...FDA has received reports of T-cell malignancies, including chimeric antigen receptor CAR-positive lymphoma, in patients who received treatment with BCMA- or …Jul 26, 2023 · BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's ... BIOL. BIOLASE, Inc. 1.4750. -0.0850. -5.45%. BIOLASE Inc (NASDAQ: BIOL) and EdgeEndo have announced the co-development of EdgePRO, a next-generation Laser-Assisted Microfluidic Irrigation device ...BIOLASE, Inc.(NASDAQ: BIOL), the global leader in dental lasers, today announced groundbreaking findings from a 12-month follow-up to a clinical trial performed at The McGuire Institute™. The findings will be published in the November 2023 issue of the Journal of Periodontology. The pioneering study was designed to meet the stringent …
Dec 5, 2023 · BIOL) stock’s latest price update. Biolase Inc (NASDAQ: BIOL) has experienced a rise in its stock price by 31.30 compared to its previous closing price of 1.15. However, the company has seen a gain of 30.17% in its stock price over the last five trading days. Benzinga reported 2023-08-04 that The most oversold stocks in the health care sector ...
LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ...
LAKE FOREST, Calif., June 5, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, is taking the necessary steps to optimize operations to capitalize on the rising ...FOOTHILL RANCH, Calif., May 13, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for its first quarter ended March 31, 2021.IRVINE, Calif., July 2, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced that the subscription period for the rights offering has commenced. If ...IRVINE, Calif., July 9, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that BIOLASE CEO Todd Norbe has been invited to participate in a ...
15 Jun 2023 ... (NASDAQ: BIOL), the global leader in dental lasers, today announced plans to open a state-of-the-art training facility, "BIOLASE Education ...
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30, 2023. BIOLASE, Inc.(NASDAQ: BIOL), the global ...
Nov 22, 2023 · BIOL Biolase Inc Statement of Ownership (sc 13g) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction ... LAKE FOREST, Calif., Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 75,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series J Convertible Redeemable …BIOL. The Nasdaq Stock Market LLC. (Nasdaq Capital Market). Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 ...BIOLASE Stock Performance. Shares of BIOL stock opened at $1.25 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 1.40 and a debt-to-equity ratio of 34.06. The firm has a 50 day moving average price of $1.78 and a two-hundred day moving average price of $11.22. BIOLASE has a 12-month low of $1.07 and a 12-month high of $175.99.FOOTHILL RANCH, Calif., Feb. 10, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), a global leader in dental lasers, today announced the closing of its previously announced bought deal offering ...Jan 6, 2022 · FOOTHILL RANCH, Calif., Jan. 6, 2022 /PRNewswire/-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products ... LAKE FOREST, Calif., Sept. 13, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten ...
26 Jul, 2023, 16:30 ET. COMMON STOCK WILL BEGIN TRADING ON SPLIT-ADJUSTED BASIS ON JULY 28, 2023. LAKE FOREST, Calif., July 26, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ) ("BIOLASE" or the ...8 Nov 2023 ... Biolase (NASDAQ:BIOL) shares are rising more than 24% with the release of positive study results. Upwork (NASDAQ:UPWK) stock is heading over ...BIOLASE, Inc. (NASDAQ:BIOL) rose 9% to $0.5707 in pre-market trading after gaining 9% on Friday. The company, last month, was granted US patent for 'Dental laser interface system and method.'01 Mar, 2022, 16:15 ET. FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that its Board of Directors ...(NASDAQ: BIOL), a global leader in dental lasers, today announced the appointment of Russell Morrow, D.D.S. as Chief Dental Officer ("CDO"), effective November 1, 2022. Dr. Samuel Low, who has served as Chief Dental Officer since 2016, will be taking on a new role as Vice President, Clinical Strategic Alliances, where he will focus on …
The answer lies in Nasdaq rules that give companies generous grace periods for companies trying to get their share price back above $1. Under the rules, a company …Of the funds tracked by Insider Monkey, Hal Mintz’s Sabby Capital has the biggest position in Biolase Inc (NASDAQ:BIOL), worth close to $0.1 million, comprising less than 0.1%% of its total 13F ...
17 Dec, 2020, 09:00 ET. IRVINE, Calif., Dec. 17, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced a collaboration with BMW Performance Center ...FOOTHILL RANCH, Calif., Sept. 8, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced its schedule of investor conferences for September 2021 ...Aug 14, 2021 · You can click the graphic below for the historical numbers, but it shows that BIOLASE had US$13.1m of debt in June 2021, down from US$16.7m, one year before. However, its balance sheet shows it ... Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in.../PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for its third quarter ended September...Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBiolase (NASDAQ: BIOL) stock is surging more than 26% with heavy trading this morning. Biodexa Pharmaceuticals (NASDAQ: BDRX) shares are gaining over 19% as a prospectus goes into effect.BIOLASE, Inc. (NASDAQ:BIOL) rose 9% to $0.5707 in pre-market trading after gaining 9% on Friday. The company, last month, was granted US patent for 'Dental laser interface system and method.'
Aug 14, 2021 · You can click the graphic below for the historical numbers, but it shows that BIOLASE had US$13.1m of debt in June 2021, down from US$16.7m, one year before. However, its balance sheet shows it ...
LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ...
Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...Apr 28, 2022 · The Nasdaq Capital Market requires, among other things, that a listing a company's common stock maintain a minimum bid price of at least $1.00 per share. Information for BIOLASE Stockholders BIOL After-Hours Quotes. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary ...BIOLASE (NASDAQ:BIOL) plummets 47.31% premarket on pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 ...Gainers BIOLASE, Inc. (NASDAQ:BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The company said i...FOOTHILL RANCH, Calif., May 13, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for its first quarter ended March 31, 2021.Jan 10, 2023 · LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public offering price of $0.35 per share or $0.34 per pre ... BIOL Edit my quotes Biolase, Inc. Common Stock (BIOL) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time After-Hours Key Data Bid Price and Ask Price The bid & ask refers to the price... May 12, 2023 · BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - Investor Relations, EVC... Biolase (NASDAQ:BIOL) has filed to offering 125,000 unites, each consisting of:One Share of Series J Convertible Preferred Stock with a Liquidation Preference of $100.00 and One Warrant to... Investing.com; Aug 30, 2023 21:35FOOTHILL RANCH, Calif., Sept. 8, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced its schedule of investor conferences for September 2021 ...Dec 1, 2023 · The firm earned $10.92 million during the quarter. BIOLASE has generated ($158.82) earnings per share over the last year ( ($158.82) diluted earnings per share). BIOLASE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 26th, 2024 based off prior year's report dates.
Graphite Bio, Inc. (Nasdaq – GRPH) Under the terms of the agreement, Graphite Bio will merge with LENZ Therapeutics in an all-stock transaction. Under the …Find the latest SEC Filings data for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.BIOLASE Inc stock price (BIOL). NASDAQ: BIOL. Buying or selling a stock that's not traded in your local currency? Don't let the currency conversion trip you ...LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten ...Instagram:https://instagram. mgk vanguardsavings account or roth irajpmorgan ultra short income etfavuv expense ratio BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its ...BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, is taking the necessary steps to optimize operations to capitalize on the rising business momentum for its market-leading dental lasers. jp morgan large cap growth r6best crypto trading course Like biting into a piece of aluminum foil, dental laser manufacturer BioLase (NASDAQ:BLTI) jarred the market's dentures with an announcement that first-quarter revenues would be well below ... one test for cancer reviews NASDAQNYSEIBEX35LSEDAXCRYPTO. Buscar. NASDAQ:BIOL. BIOLASE Inc. Sector. Health. Industry. Medical supplies and equipment. 1,65 $ Last price. -0,03 $ VARIATION.BIOL- running earnings 8/10 LONG BIOL had a triple top in late July so this is a logical long target at 8,0, With earnings in less than two days, volumes above the mean in the past couple of days and a decent price-volume product trend coupled with a Price Monetum Oscillator without any signs of topping out in a momentum stall BIOL had a triple top in late July so this is a logical long target ...